help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-0222
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
144/10/4306    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fülöp, A. K.
Right arrow Articles by Kovács, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fülöp, A. K.
Right arrow Articles by Kovács, K. J.
Endocrinology Vol. 144, No. 10 4306-4314
Copyright © 2003 by The Endocrine Society

Hyperleptinemia, Visceral Adiposity, and Decreased Glucose Tolerance in Mice with a Targeted Disruption of the Histidine Decarboxylase Gene

András K. Fülöp, Anna Földes, Edit Buzás, Krisztina Hegyi, Ildikó H. Miklós, László Romics, Monika Kleiber, András Nagy, András Falus and Krisztina J. Kovács

Laboratory of Molecular Neuroendocrinology (A.Fö., I.H.M., K.J.K.), Institute of Experimental Medicine, H-1083 Budapest, Hungary; Department of Genetics, Cell, and Immunobiology (A.K.F., E.B., K.H., A.Fa.) and 3rd Department of Internal Medicine (L.R., M.K.), Semmelweis University, H-1089 Budapest, Hungary; Samuel Lunenfeld Research Institute (A.N.), Mount Sinai Hospital, Toronto, Canada M5G 1X5; and Molecular Immunology Research Group (A.Fa.), Hungarian Academy of Sciences, H-1089 Budapest, Hungary

Address all correspondence and requests for reprints to: Krisztina J. Kovács, Ph.D., Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Szigony u. 43, H-1083 Budapest, Hungary. E-mail: kovacs{at}koki.hu.

Histamine has been referred to as an anorexic factor that decreases appetite and fat accumulation and affects feeding behavior. Tuberomammillary histaminergic neurons have been implicated in central mediation of peripheral metabolic signals such as leptin, and centrally released histamine inhibits ob gene expression. Here we have characterized the metabolic phenotype of mice that completely lack the ability to produce histamine because of targeted disruption of the key enzyme in histamine biosynthesis (histidine decarboxylase, HDC). Histochemical analyses confirmed the lack of HDC mRNA, histamine immunoreactivity, and histaminergic innervation throughout the brain of gene knockout mouse. Aged histamine-deficient (HDC-/-) mice are characterized by visceral adiposity, increased amount of brown adipose tissue, impaired glucose tolerance, hyperinsulinemia, and hyperleptinemia. Histamine-deficient animals are not hyperphagic but gain more weight and are calorically more efficient than wild-type controls. These metabolic changes presumably are due to the impaired regulatory loop between leptin and hypothalamic histamine that results in orexigenic dominance through decreased energy expenditure, attenuated ability to induce uncoupling protein-1 mRNA in the brown adipose tissue and defect in mobilizing energy stores. Our results further support the role of histamine in regulation of energy homeostasis.




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
H. L. Haas, O. A. Sergeeva, and O. Selbach
Histamine in the Nervous System
Physiol Rev, July 1, 2008; 88(3): 1183 - 1241.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Yoshimoto, Y. Miyamoto, K. Shimamura, A. Ishihara, K. Takahashi, H. Kotani, A. S. Chen, H. Y. Chen, D. J. MacNeil, A. Kanatani, et al.
Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus
PNAS, September 12, 2006; 103(37): 13866 - 13871.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Musio, B. Gallo, S. Scabeni, M. Lapilla, P. L. Poliani, G. Matarese, H. Ohtsu, S. J. Galli, R. Mantegazza, L. Steinman, et al.
A Key Regulatory Role for Histamine in Experimental Autoimmune Encephalomyelitis: Disease Exacerbation in Histidine Decarboxylase-Deficient Mice
J. Immunol., January 1, 2006; 176(1): 17 - 26.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Masaki, S. Chiba, T. Yasuda, H. Noguchi, T. Kakuma, T. Watanabe, T. Sakata, and H. Yoshimatsu
Involvement of Hypothalamic Histamine H1 Receptor in the Regulation of Feeding Rhythm and Obesity
Diabetes, September 1, 2004; 53(9): 2250 - 2260.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society